The prognostic value of quality of life scores during treatment for oesophageal cancer

被引:107
作者
Blazeby, JM [1 ]
Brookes, ST
Alderson, D
机构
[1] Bristol Royal Infirm, Div Surg, Bristol BS2 8HW, Avon, England
[2] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
关键词
quality of life; oesophageal neoplasms; survival; prognosis; European Organisation for Research and Treatment of Cancer;
D O I
10.1136/gut.49.2.227
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background - Quality of life (QL) data are useful to evaluate the effectiveness of treatment. Accumulating evidence suggests that QL data may predict survival. Aims - In this study we investigated if baseline QL scores and changes in QL scores before and after intervention are prognostic for patients with oesophageal cancer. Patients - Between 1993 and 1995, 92 consecutive new patients with oesophageal cancer were studied; 89 were followed until death or the end of the study period (survival of seven patients was censored in May 1999). Methods - All patients completed the European Organisation for Research and Treatment of Cancer (EORTC) core questionnaire (EORTC QLQ-C30) and the dysphagia scale of the oesophageal module (EORTC QLQ-OES24) before treatment and at regular intervals throughout the study. Cox's proportional hazards models assessed the impact of baseline QL variables and changes in QL scores on survival. Results - Cox's proportional hazards models, adjusting for associations between QL scores, age, and TNM stage, found that physical function at baseline was significantly associated with survival (p=0.002). An increase in physical function score of 10 points corresponded to a 12% reduction in the likelihood of death at any given time (95% confidence intervals 4-18%). Further exploratory multivariable analyses suggested that improvement in emotional function six months after treatment was significantly related to longer survival (p <0.0001), Conclusions - These data provide evidence to support a relationship between patient rated scores of QL and survival. Further understanding of the associations between QL and clinical variables is needed.
引用
收藏
页码:227 / 230
页数:4
相关论文
共 21 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] EVALUATION OF THE PALLIATIVE EFFECT OF RADIOTHERAPY FOR ESOPHAGEAL-CARCINOMA
    ALBERTSSON, M
    EWERS, SB
    WIDMARK, H
    HAMBRAEUS, G
    LILLOGIL, R
    RANSTAM, J
    [J]. ACTA ONCOLOGICA, 1989, 28 (02) : 267 - 270
  • [3] Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer
    Blazeby, JM
    Alderson, D
    Winstone, K
    Steyn, R
    Hammerlid, E
    Arraras, J
    Farndon, JR
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) : 1912 - 1917
  • [4] QUALITY-OF-LIFE MEASUREMENT IN PATIENTS WITH ESOPHAGEAL CANCER
    BLAZEBY, JM
    WILLIAMS, MH
    BROOKES, ST
    ALDERSON, D
    FARNDON, JR
    [J]. GUT, 1995, 37 (04) : 505 - 508
  • [5] Blazeby JM, 2000, CANCER, V88, P1781
  • [6] PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES IN A TRIAL OF CHEMOTHERAPY WITH OR WITHOUT INTERFERON IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    COATES, A
    THOMSON, D
    MCLEOD, GRM
    HERSEY, P
    GILL, PG
    OLVER, IN
    KEFFORD, R
    LOWENTHAL, RM
    BEADLE, G
    WALPOLE, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) : 1731 - 1734
  • [7] Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy
    Coates, A
    Porzsolt, F
    Osoba, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) : 1025 - 1030
  • [8] PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER
    COATES, A
    GEBSKI, V
    SIGNORINI, D
    MURRAY, P
    MCNEIL, D
    BYRNE, M
    FORBES, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) : 1833 - 1838
  • [9] Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992-1994 patterns of care study
    Coia, LR
    Minsky, BD
    Berkey, BA
    John, MJ
    Haller, D
    Landry, J
    Pisansky, TM
    Willett, CG
    Hoffman, JP
    Owen, JB
    Hanks, GE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 455 - 462
  • [10] COX DR, 1972, J R STAT SOC B, V34, P187